12 March 2020
Visiongain has launched a new pharma report Global Ophthalmic Devices Market 2020-2030: Vision Care, Surgical, Diagnostics and Monitoring, OCT Machines, Autorefractor/Keratometer, Fundus Camera, Slit Lamp, OR Microscope, Optical Biometry, Tonometer, Perimeter, Cataract Surgery, Refractive Surgery, Vitro Retinal Surgery, Glaucoma Surgery, Spectacles, Contact Lenses, Daily Disposables.
The medical devices industry is one of the largest and fastest growing markets in the medical and pharmaceutical industries. Rise in geriatric population has led to a rise in ophthalmic conditions such as cataract and diabetic retinopathy. Moreover, rising disposable income, growing awareness of ophthalmic conditions coupled with favourable reimbursement policies of government will further boost the overall growth of ophthalmic surgical devices market.
The lead analyst of the report commented "The global ophthalmic surgical and vision care markets are large, dynamic and growing. As the world’s population grows and ages, the need for quality eye care is expanding and evolving. Advancements in technology have led to the replacement of conventional techniques and devices. There is an increasing prevalence of many eye diseases, especially those linked to chronic diseases such as diabetes. A relatively rich R&D pipeline will improve the diagnostics of ophthalmic diseases and outcomes of surgical procedures.
Current limitations of pharmaceutical treatments, as well of ophthalmic diagnostics and monitoring and surgical devices will continue to drive innovation. Patient compliance and cost effectiveness will be a key factor to consider in future device development."
Leading companies featured in the report include Abbott Medical Optics (AMO), Alcon, Bausch and Lomb (B&L), Carl Zeiss AG Meditec, Haag-Streit Holding AG, Hoya, Johnson & Johnson (J&J), Nidek, STAAR, TopCon, Zeimer Ophthalmic Solutions.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to firstname.lastname@example.org or call her on +44 (0) 207 336 6100.
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
Increasing prevalence of cancers and rising demand for advanced therapies for cancer treatment are the major factors driving the demand for cellular immunotherapies.
15 June 2021
Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions.
14 June 2021
Rising preference for personalised medicine in developed as well as developing economies coupled with increasing investment by biotechnological and pharmaceutical companies for drug discovery is expected to increase NGS market concentration over the forecast period.
04 June 2021
The rising frequency of bacterial and viral diseases coupled with increased focus on immunisation programmes are two main reasons that are expected to boost the global anti-infective vaccines market’s growth in the coming years.